House undermining Cabinet’s pharma pricing agreement? The House of Representatives is raising objections to the Cabinet’s price agreement with pharma manufacturers, on which the Council of Ministers signed off earlier this week. The agreement, brokered by the Health Ministry, which sets the price of meds in Egypt, would see the price of locally manufactured meds rise 15% every six months, while imported SKUs would be allowed to rise 20% every six months. Al Borsa is now citing an unnamed parliamentarian as saying that the government should cut customs or taxes for pharma manufacturers or provide subsidized electricity and water before allowing a price hike. “We cannot oppose raising the price of medicines to ensure they remain available to citizens. At the same time, we cannot accept that price of medicine rises continuously. As a result, we have required the minister [of health] to review the proposal” once more.